Status:
UNKNOWN
The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission
Lead Sponsor:
Rabin Medical Center
Conditions:
Hearing Status
Eligibility:
All Genders
1-18 years
Brief Summary
Pediatric patients, during their illness often treated with furosemide (Lasix) continuous drip, often, with dosages above 4-6mg/kg/day (the recommended dose). This study will monitor hearing status o...
Detailed Description
This study will record hearing status, by acoustic emission, of critically ill children, treated with different dosages of furosemide drip. Acoustic emission test will be done prior to therapy and q4...
Eligibility Criteria
Inclusion
- All children admitted to Pediatric ICU who are treated with furosemide continuous drip.
Exclusion
- Children with known hearing abnormalities prior to treatment.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00945386
Start Date
August 1 2009
End Date
August 1 2010
Last Update
July 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric ICU, Schneider Children's Hospital
Petah Tikva, Israel, 49202